Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.296
+0.014 (4.92%)
At close: Mar 3, 2026, 4:00 PM EST
0.296
0.00 (0.00%)
After-hours: Mar 3, 2026, 4:04 PM EST
Cue Biopharma Stock Forecast
CUE's stock price has decreased by -75.92% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Cue Biopharma stock have an average target of 3.00, with a low estimate of 2.00 and a high estimate of 4.00. The average target predicts an increase of 912.83% from the current stock price of 0.30.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 25, 2025.
Analyst Ratings
The average analyst rating for Cue Biopharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +1,250.44% | Aug 25, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $2 | Buy | Reiterates | $2 | +575.22% | Apr 2, 2025 |
| Stifel | Stifel | Strong Buy Maintains $8 → $4 | Strong Buy | Maintains | $8 → $4 | +1,250.44% | Aug 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $2 | Buy | Maintains | $15 → $2 | +575.22% | Jul 26, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $3 | Buy | Maintains | $8 → $3 | +912.83% | Jul 26, 2024 |
Financial Forecast
Revenue This Year
8.08M
from 9.29M
Decreased by -13.00%
Revenue Next Year
10.10M
from 8.08M
Increased by 25.00%
EPS This Year
-0.41
from -0.72
EPS Next Year
-0.48
from -0.41
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.4M | 10.5M | ||||
| Avg | 8.1M | 10.1M | ||||
| Low | 7.8M | 9.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -9.6% | 30.0% | ||||
| Avg | -13.0% | 25.0% | ||||
| Low | -15.6% | 21.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.43 | -0.50 | |||
| Avg | -0.41 | -0.48 | |||
| Low | -0.40 | -0.47 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.